Step Pharma announces completion of €38 million Series C financing • Financing will support the…
Continue Reading-
Complement Therapeutics Receives FDA IND Clearance to Advance CTx001 into Opti-GAIN, a Phase I/II Clinical Trial in Geographic Atrophy secondary to AMD
Complement Therapeutics Receives FDA IND Clearance...
Continue Reading -
Ribbon Bio and Scala Biodesign into Powerful Partnership Focused on Customers
In Powerful Partnership Focused on Customers, Ribbon Bio and Scala Biodesign Advance Enzyme Innovation with…
Continue Reading -
ARTHEx Biotech Upsizes Series B Financing Round to $87M to Advance Lead Program ATX-01 in Myotonic Dystrophy Type 1 and Expand Pipeline of Targeted RNA Medicines
ARTHEx Biotech Upsizes Series B Financing Round to $87M...
Continue Reading -
Hadean Ventures is looking for an Investment Intern
Investment Intern
Continue Reading -
Investment intern – Oslo
Hadean Ventures is looking for an Investment Intern to join our team in Oslo! As…
Continue Reading -
Gesynta Pharma Announces Second Closing of Series B Now Totaling SEK 347m – HealthCap and Hadean Growth Fund Join Strong Investor Syndicate
STOCKHOLM, SWEDEN – July 22, 2025. Gesynta Pharma AB today announced it has raised an…
Continue Reading -
SAGA Diagnostics® Announces Medicare Coverage for Pathlight™ MRD Test in Breast Cancer Across All Subtypes
Coverage marks a pivotal step in expanding access to ultra-sensitive MRD detection for breast cancer…
Continue Reading -
Ribbon Bio and Syngoi Technologies Commence Strategic Collaboration to Advance Gene Therapies with Synthetic DNA
Collaboration builds upon Syngoi’s synthetic DNA manufacturing capabilities and Ribbon’s algorithm-driven technology to produce pristine…
Continue Reading
